Pricing Log in Create free account

GH Research PLC (GHRS) vs Inhibrx Biosciences, Inc. (INBX)

GH Research PLC and Inhibrx Biosciences, Inc. are both Biotechnology companies. GH Research PLC and Inhibrx Biosciences, Inc. are of similar size ($1.3B and $1.3B). Across the 9 metrics below, GH Research PLC leads on 6 and Inhibrx Biosciences, Inc. on 3.

Valuation

Metric GHRS INBX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 446.70 9.71
P/B 3.36 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 460.33 9.21
Earnings yield (5.51%) (9.89%) (33.15%)
Free cash flow yield (4.29%) (9.37%) (25.50%)

Profitability

Metric GHRS INBX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (18.79%) (1,773.60%) (56.36%)
Return on assets (18.16%) (75.44%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GHRS INBX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (5.33%) (108.03%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GHRS INBX Biotechnology median
Debt to equity 0.00 (3.33) 0.00
Current ratio 28.70 5.07 4.72
Net debt to EBITDA 4.65 0.18 0.96

Dividend

Metric GHRS INBX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GHRS INBX Biotechnology median
Market cap 1.29b 1.33b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack